Rotavirus Gastroenteritis — How Vaccination Changed the Illness for Young Children

Lead

It starts with forceful vomiting, then watery diarrhea that continues for days. For small children, that kind of fluid loss can become a direct danger. Rotavirus gastroenteritis has been a leading cause of severe gastroenteritis hospitalizations in children under 5 worldwide — as recently as 2013, it was estimated to cause approximately 215,000 deaths annually in that age group [1]. In countries where routine vaccination has been introduced, hospitalization rates have fallen sharply. What has changed, and what hasn't — this article covers both.

The Virus and Its Clinical Course

Rotavirus is a double-stranded RNA virus with multiple genotypes defined by G-type and P-type combinations and extremely high transmissibility. Fecal-oral transmission is the primary route. In the Northern Hemisphere, the peak season is typically late winter to spring — February through April in many countries.

Incubation is one to three days. The characteristic pattern is vomiting first, then watery diarrhea, often with fever [5]. Diarrhea can last five to eight days, during which substantial fluid and electrolyte losses accumulate. Severe cases can involve altered consciousness or seizures, but the dominant risk is progressive dehydration.

Because young children have proportionally large body fluid volumes, dehydration can advance quickly. Watching what goes out and tracking how much fluid is coming back in is the backbone of home management.

What Vaccination Changed

Two oral live attenuated vaccines were approved in 2006: Rotarix (monovalent, two oral doses) and RotaTeq (pentavalent, three oral doses). In the pivotal trials, Rotarix reduced both severe rotavirus gastroenteritis and rotavirus-related hospitalization by 85% [3], and RotaTeq showed 98% efficacy against severe gastroenteritis and a 94.5% reduction in rotavirus-related hospitalizations and emergency department visits [2]. In 2013, the WHO position paper recommended incorporating rotavirus vaccine into all national immunization programs [4].

In Japan, rotavirus vaccination became part of the routine immunization schedule in October 2020 and is now provided at no cost. Even before that, during the voluntary-vaccination period, regional studies across Japan reported roughly 76–86% reductions in rotavirus hospitalization rates among children under 5 [6].

That said, vaccination coverage is not universal, vaccine failure occurs at some rate in all recipients, and caregivers in the pre-vaccine generation can still transmit the virus to infants. These realities are worth understanding even in a vaccine era.

Recognizing Dehydration and Using ORS

Mild dehydration: dry mouth and tongue, few or no tears when crying. Moderate to severe: sunken eyes, skin that returns slowly after being gently pinched (decreased skin turgor). In infants, a sunken fontanelle is an additional sign.

Severe dehydration: depressed consciousness, no urine for 6–8 hours. This state requires IV fluid replacement; there is no time to attempt oral rehydration at this point.

For mild-to-moderate dehydration, oral rehydration solution (ORS) is effective. Its balanced composition of electrolytes — higher in sodium, lower in sugar than sports drinks and juices — matches how the intestine actually absorbs water through sodium–glucose cotransport [8]. The small-frequent approach for a vomiting child: start with about 5 mL (one teaspoon) every five minutes and increase gradually as tolerated [7,8]. The CDC guidance encourages families to keep ORS at home and to start it as soon as diarrhea begins [7] — commercially available products such as OS-1 in Japan, or Pedialyte and similar products elsewhere.

If vomiting keeps rehydration from making progress, if urine output (wet diapers) drops noticeably, or if your child becomes listless and less responsive, it's time to call or go in. If you can't tell whether it's safe to wait, that alone is a reason to call [7].

Putting It Into Practice

• Log the start time and frequency of vomiting and diarrhea; this is directly useful for the physician's assessment of severity at any clinic visit
• Keep one bottle of oral rehydration solution at home
• Prevent secondary spread to siblings and caregivers with thorough handwashing after diaper changes — soap and running water, not alcohol alone
• Vaccinated children may still develop rotavirus illness; if they do, the course is often milder, but the same monitoring applies

Summary

Rotavirus vaccines have substantially changed the risk landscape for severe gastroenteritis in young children — but not eliminated the disease. Recognizing the signs of dehydration and knowing how to use oral rehydration solution remain practical knowledge for the vaccine era. For many families, the difference between managing at home and needing hospitalization comes down to how effectively hydration is maintained.

References

1. Tate JE, Burton AH, Boschi-Pinto C, Parashar UD; World Health Organization–Coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105. doi:10.1093/cid/civ1013. PMID: 27059362.
2. Vesikari T, Matson DO, Dennehy P, et al.; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664. PMID: 16394299.
3. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22. doi:10.1056/NEJMoa052434. PMID: 16394298.
4. WHO. Rotavirus vaccines: WHO position paper — January 2013. Wkly Epidemiol Rec. 2013;88(5):49–64. PMID: 23424730.
5. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22(3):259–267. doi:10.3109/00365549009027046. PMID: 2371542.
6. Noguchi A. [Effectiveness of rotavirus vaccine in Japan] (in Japanese). Infectious Agents Surveillance Report (IASR). 2019;40(12):212–213. National Institute of Infectious Diseases, Japan.
7. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep. 2003;52(RR-16):1–16. PMID: 14627948.
8. Cellucci MF. Oral rehydration. MSD Manual Professional Version (last reviewed July 2025). https://www.msdmanuals.com/professional/pediatrics/dehydration-and-fluid-therapy-in-children/oral-rehydration